Cargando…

Effect of unilateral adrenalectomy on the quality of life of patients with lateralized primary aldosteronism

BACKGROUND: Primary aldosteronism (PA) is associated with an increased prevalence of anxiety and depression. Subnormal quality of life (QoL) scores in PA patients may be improved after surgical treatment. The aim of the study was to assess the impact of surgery on health-related QoL and depression s...

Descripción completa

Detalles Bibliográficos
Autores principales: Citton, Marilisa, Viel, Giovanni, Torresan, Francesca, Rossi, Gian Paolo, Iacobone, Maurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402567/
https://www.ncbi.nlm.nih.gov/pubmed/31074381
http://dx.doi.org/10.1186/s12893-018-0432-1
_version_ 1783566785137606656
author Citton, Marilisa
Viel, Giovanni
Torresan, Francesca
Rossi, Gian Paolo
Iacobone, Maurizio
author_facet Citton, Marilisa
Viel, Giovanni
Torresan, Francesca
Rossi, Gian Paolo
Iacobone, Maurizio
author_sort Citton, Marilisa
collection PubMed
description BACKGROUND: Primary aldosteronism (PA) is associated with an increased prevalence of anxiety and depression. Subnormal quality of life (QoL) scores in PA patients may be improved after surgical treatment. The aim of the study was to assess the impact of surgery on health-related QoL and depression status of patients suffering from PA, comparing the results with a control group of patients undergoing surgery for non-secreting adrenal tumors. METHODS: Data on QoL and depression status were prospectively collected, from January 2014 to January 2017, before, early after surgery (at 1 month) and at late follow up (at least 6 months) in patients with unilateral PA and in a control group with non-secreting adrenal tumors submitted to unilateral laparoscopic adrenalectomy. QoL was assessed using the Short Form 36 (SF-36) Health Survey for Physical (PCS) and Mental Component (MCS); the depression status by a 20-item depression scale (DS) questionnaire. RESULTS: Twenty-six PA patients and 15 controls were recruited. Biochemical cure of the disease was achieved following surgery in all PA patients; hypertension was cured in 31% of cases and improved in the remaining 69% of cases. No morbidity occurred in both groups. There were no significant differences between PA patients and controls concerning demographics, preoperative PCS, MCS and DS values. In patients with PA, MCS values improved at early (42.72 ± 13.68 vs 51.56 ± 9.03, p = 0.0005) and late follow up (42.72 ± 13.68 vs 51.81 ± 7.04, p < 0.0001); also DS values improved at early (15.92 ± 11.98 vs 8.3 ± 8.8, p = 0.0002) and late follow up (15.92 ± 11.98 vs 4.57 ± 6.11, p < 0.0001). In PA patients PCS values significantly improved at late follow up (51.02 ± 8.04 vs 55.85 ± 5.1, p = 0.013). Also in controls an improvement of MCS and DS scores was found at early and late follow up compared to preoperative values, while no significant differences in PCS were found. CONCLUSIONS: Both PA and non-secreting adrenal tumors affect health-related QoL, worsening MCS and DS scores. Adrenalectomy is effective in curing PA, and improving MCS and DS scores at early and late follow-up, in patients with PA and non-secreting adrenal tumors. In PA patient surgery also significantly improves PCS at late follow up.
format Online
Article
Text
id pubmed-7402567
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-74025672020-08-07 Effect of unilateral adrenalectomy on the quality of life of patients with lateralized primary aldosteronism Citton, Marilisa Viel, Giovanni Torresan, Francesca Rossi, Gian Paolo Iacobone, Maurizio BMC Surg Research Article BACKGROUND: Primary aldosteronism (PA) is associated with an increased prevalence of anxiety and depression. Subnormal quality of life (QoL) scores in PA patients may be improved after surgical treatment. The aim of the study was to assess the impact of surgery on health-related QoL and depression status of patients suffering from PA, comparing the results with a control group of patients undergoing surgery for non-secreting adrenal tumors. METHODS: Data on QoL and depression status were prospectively collected, from January 2014 to January 2017, before, early after surgery (at 1 month) and at late follow up (at least 6 months) in patients with unilateral PA and in a control group with non-secreting adrenal tumors submitted to unilateral laparoscopic adrenalectomy. QoL was assessed using the Short Form 36 (SF-36) Health Survey for Physical (PCS) and Mental Component (MCS); the depression status by a 20-item depression scale (DS) questionnaire. RESULTS: Twenty-six PA patients and 15 controls were recruited. Biochemical cure of the disease was achieved following surgery in all PA patients; hypertension was cured in 31% of cases and improved in the remaining 69% of cases. No morbidity occurred in both groups. There were no significant differences between PA patients and controls concerning demographics, preoperative PCS, MCS and DS values. In patients with PA, MCS values improved at early (42.72 ± 13.68 vs 51.56 ± 9.03, p = 0.0005) and late follow up (42.72 ± 13.68 vs 51.81 ± 7.04, p < 0.0001); also DS values improved at early (15.92 ± 11.98 vs 8.3 ± 8.8, p = 0.0002) and late follow up (15.92 ± 11.98 vs 4.57 ± 6.11, p < 0.0001). In PA patients PCS values significantly improved at late follow up (51.02 ± 8.04 vs 55.85 ± 5.1, p = 0.013). Also in controls an improvement of MCS and DS scores was found at early and late follow up compared to preoperative values, while no significant differences in PCS were found. CONCLUSIONS: Both PA and non-secreting adrenal tumors affect health-related QoL, worsening MCS and DS scores. Adrenalectomy is effective in curing PA, and improving MCS and DS scores at early and late follow-up, in patients with PA and non-secreting adrenal tumors. In PA patient surgery also significantly improves PCS at late follow up. BioMed Central 2019-04-24 /pmc/articles/PMC7402567/ /pubmed/31074381 http://dx.doi.org/10.1186/s12893-018-0432-1 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Citton, Marilisa
Viel, Giovanni
Torresan, Francesca
Rossi, Gian Paolo
Iacobone, Maurizio
Effect of unilateral adrenalectomy on the quality of life of patients with lateralized primary aldosteronism
title Effect of unilateral adrenalectomy on the quality of life of patients with lateralized primary aldosteronism
title_full Effect of unilateral adrenalectomy on the quality of life of patients with lateralized primary aldosteronism
title_fullStr Effect of unilateral adrenalectomy on the quality of life of patients with lateralized primary aldosteronism
title_full_unstemmed Effect of unilateral adrenalectomy on the quality of life of patients with lateralized primary aldosteronism
title_short Effect of unilateral adrenalectomy on the quality of life of patients with lateralized primary aldosteronism
title_sort effect of unilateral adrenalectomy on the quality of life of patients with lateralized primary aldosteronism
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402567/
https://www.ncbi.nlm.nih.gov/pubmed/31074381
http://dx.doi.org/10.1186/s12893-018-0432-1
work_keys_str_mv AT cittonmarilisa effectofunilateraladrenalectomyonthequalityoflifeofpatientswithlateralizedprimaryaldosteronism
AT vielgiovanni effectofunilateraladrenalectomyonthequalityoflifeofpatientswithlateralizedprimaryaldosteronism
AT torresanfrancesca effectofunilateraladrenalectomyonthequalityoflifeofpatientswithlateralizedprimaryaldosteronism
AT rossigianpaolo effectofunilateraladrenalectomyonthequalityoflifeofpatientswithlateralizedprimaryaldosteronism
AT iacobonemaurizio effectofunilateraladrenalectomyonthequalityoflifeofpatientswithlateralizedprimaryaldosteronism